Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

A Randomized Phase II Study Evaluating the Efficacy and Safety of Deferasirox Versus Deferoxamine in Patients with Sickle Cell Disease (SCD): 2-Year Results Including Pharmacokinetics (PK) and Safety of Deferasirox with Concomitant Hydroxyurea Therapy

Elliott Vichinsky, MD, Marcela Torres, MD, Jonathan Glass, MD, Caterina P Minniti, MD, Stéphane Barrette, MD, Dany Habr, MD, Nicola Lynch, MS, Yiyun Zhang, Beatrice Files, MD

Blood (2011) 118 (21): 1082.

https://doi.org/10.1182/blood.V118.21.1082.1082

Published: 2011

Journal Articles

Novel Three- and Four-Drug Combination Regimens of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Previously Untreated Multiple Myeloma: Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study

Shaji Kumar, MD, Ian W. Flinn, MD, PhD, Paul G Richardson, MD, Parameswaran Hari, MD, Natalie Scott Callander, MD, Stephen J. Noga, MD, PhD, A. Keith Stewart, MD, Jonathan Glass, MD, FACP, Robert M. Rifkin, MD, Jeffrey L Wolf, MD, Jose Estevam, BS, George Mulligan, PhD, Hongliang Shi, MS, Iain J. Webb, MD, FRCPC, S. Vincent Rajkumar, MD

Blood (2010) 116 (21): 621.

https://doi.org/10.1182/blood.V116.21.621.621

Published: 2010

Journal Articles

Impact of Health Care Funding on overall Survival of Patients with Multiple Myeloma and Monoclonal Gammopathy of Uncertain Significance.

Srinivas S Devarakonda, MD, Binu S. Nair, MD, Ryan A. Gonzales, MD, Runhua Shi, MD, PhD, Nebu Koshy, MD, Gary Burton, MD, Jonathan Glass, MD, Francesco Turturro, MD

Blood (2010) 116 (21): 3821.

https://doi.org/10.1182/blood.V116.21.3821.3821

Published: 2010

Journal Articles

Phase 1/2 Clinical Trial of HQK-1001, An Oral Fetal Hemoglobin Stimulant, In Sickle Cell Anemia

Abdullah Kutlar, MD, Kenneth I. Ataga, MD, Marvin Reid, PhD, Loray A Blair-Britt, MD, Elliott Vichinsky, MD, Lynne Neumayr, MD, Richard J. Labotka, MD, MS, Jonathan Glass, MD, FACP, Andrea Small-WIlliams, MBBS, DM(HAEM), Jeffrey Keefer, MD, PhD, Ling Shen, MD, Michael S Boosalis, PhD, Audrey Thomson, BSc, Patrick Bobbitt, BS, Wayne Wallis, MD, Elsa Johnson, MBA, Ronald J Berenson, MD, Susan P Perrine, MD

Blood (2010) 116 (21): 943.

https://doi.org/10.1182/blood.V116.21.943.943

Published: 2010

Journal Articles

Therapeutic Response to Granulocyte Colony-Stimulating Factor in a Case of Selective IgA Deficiency (SIgAD) with Chronic Neutropenia.

Sarada Gummadi, MD, Jonathan Glass, MD

Blood (2009) 114 (22): 4512.

https://doi.org/10.1182/blood.V114.22.4512.4512

Published: 2009

Journal Articles

Novel Three– and Four–Drug Combinations of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Newly Diagnosed Multiple Myeloma: Encouraging Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study.

Shaji Kumar, Ian W. Flinn, Parameswaran N. Hari, Natalie Callander, Stephen J. Noga, A. Keith Stewart, Jonathan Glass, Noopur Raje, Robert M. Rifkin, Hongliang Shi, Iain J. Webb, Paul G. Richardson, S. Vincent Rajkumar

Blood (2009) 114 (22): 127.

https://doi.org/10.1182/blood.V114.22.127.127

Published: 2009

Journal Articles

High through-Put Screening of Chemicals That Stimulate Iron Uptake: A Novel Approach to Discovery of Anti-Cancer Drugs

Zhen Li, Sarah Bezucha, Floyd Galiano, Hong Yin, Jonathan Glass

Blood (2008) 112 (11): 5028.

https://doi.org/10.1182/blood.V112.11.5028.5028

Published: 2008

Journal Articles

Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study

Shaji Kumar, MD, Ian W Flinn, MD, PhD, Stephen J. Noga, MD, PhD, Parameswaran Hari, MD, MS, Robert M. Rifkin, MD, Natalie Scott Callander, MD, Manish Bhandari, MD, Jeffrey Lee Wolf, MD, Cristina Gasparetto, MD, Amrita Krishnan, MD, FACP, Daren D Grosman, MD, PhD, Jonathan Glass, MD, Entezam Asim Sahovic, MD, Hongliang Shi, MS, Iain J. Webb, MD, Paul Richardson, MD, S. Vincent Rajkumar, MD

Blood (2008) 112 (11): 93.

https://doi.org/10.1182/blood.V112.11.93.93

Published: 2008

Journal Articles

DMT1 Expression Is Regulated by DMT1 Associated Protein (DAP) in K562 Cells.

Yasumasa Okazaki, MD, PhD, Hong Yin, M.D. Ph.D., Yuxiang Ma, M.D. Ph.D., Emiko Okazaki, Mary Yeh, Ph.D., Kwo-yih Yeh, Ph.D., Jonathan Glass, M.D.

Blood (2007) 110 (11): 2661.

https://doi.org/10.1182/blood.V110.11.2661.2661

Published: 2007

Journal Articles

Inpatient Pharmaceutical Cost of Hematological Agents: A Single Center Report.

Charles V. Wendling, MD, Jonathan Glass, MD, Perry G. Rigby, MD

Blood (2006) 108 (11): 5491.

https://doi.org/10.1182/blood.V108.11.5491.5491

Published: 2006

Journal Articles

Therapeutic Dilemma of Chemotherapy Dosing in Morbidly Obese Patient with AML: A Case Report and a Review of the Literature.

Sakeer Hussain, MD, Jonathan Glass, MD, Oscar Ballester, MD

Blood (2006) 108 (11): 5534.

https://doi.org/10.1182/blood.V108.11.5534.5534

Published: 2006

Journal Articles

Protoporphyrin IX Down-Regulates DMT1 Associated Protein (DAP) in K562 Cells.

Yasumasa Okazaki, MD, PhD, Hong Yin, MD, PhD, Yuxiang Ma, MD, PhD, Mary Yeh, MS, Kwo-yih Yeh, PhD, Jonathan Glass, MD

Blood (2006) 108 (11): 1548.

https://doi.org/10.1182/blood.V108.11.1548.1548

Published: 2006

Journal Articles

The Interaction of MOZ-TIF2 with Histone Chaperon Proteins CAF-1A and Asf1b Alters MOZ Regulated Gene Expression.

Hong Yin, MD, PhD, Jonathan Glass, MD, Kerry L. Blanchard, MD, PhD

Blood (2006) 108 (11): 2208.

https://doi.org/10.1182/blood.V108.11.2208.2208

Published: 2006

Journal Articles

Iron Transport in Intestinal Epithelial Cells Occurs by Transcytosis. A Fluorescent Metal-Sensor Study.

Yuxiang Ma, MD, PhD, Mary Yeh, MS, Kwo-yih Yeh, PhD, Jonathan Glass, MD

Blood (2005) 106 (11): 3583.

https://doi.org/10.1182/blood.V106.11.3583.3583

Published: 2005

Journal Articles

The DMT1 Associated Protein (DAP) Regulates Iron Uptake by Erythroid Cells.

Jonathan Glass, MD, Yi Chen, PhD, Yuxiang Ma, MD, PhD, Mary Yeh, MS, Kwo-yih Yeh, PhD

Blood (2004) 104 (11): 53.

https://doi.org/10.1182/blood.V104.11.53.53

Published: 2004

Journal Articles

Troglitazone Exerts a Cell-Dependent Effect on the Extracellular Secretion of VEGF 165 Independently from the Rapamycin Sensitivity or the Level of eIF4E Expression in AML-Derived Cells.

Ellen Friday, PhD, Jonathan Glass, MD, Francesco Turturro, MD

Blood (2004) 104 (11): 4363.

https://doi.org/10.1182/blood.V104.11.4363.4363

Published: 2004

Journal Articles

Altered Expression Profile of Global Genes in U937 Cells Stably Transfected with a Leukemia Fusion Gene: MOZ-TIF2.

Hong Yin, Ph.D, Kerry L. Blanchard, Ph.D, M.D, Jonathan Glass, M.D.

Blood (2004) 104 (11): 4284.

https://doi.org/10.1182/blood.V104.11.4284.4284

Published: 2004

Journal Articles

Apo-transferrin is internalized and routed differently from Fe-transferrin by Caco-2 cells: a confocal microscopy study of vesicular transport in intestinal cells

Xavier Alvarez-Hernandez, Margaret Smith, Jonathan Glass

Blood (2000) 95 (2): 721–723.

https://doi.org/10.1182/blood.V95.2.721

Published: 2000

Journal Articles

The Effect of Apotransferrin on Iron Release From Caco-2 Cells, an Intestinal Epithelial Cell Line

Xavier Alvarez-Hernandez, Margaret Smith, Jonathan Glass

Blood (1998) 91 (10): 3974–3979.

https://doi.org/10.1182/blood.V91.10.3974

Published: 1998

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

A Randomized Phase II Study Evaluating the Efficacy and Safety of Deferasirox Versus Deferoxamine in Patients with Sickle Cell Disease (SCD): 2-Year Results Including Pharmacokinetics (PK) and Safety of Deferasirox with Concomitant Hydroxyurea Therapy

Novel Three- and Four-Drug Combination Regimens of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Previously Untreated Multiple Myeloma: Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study

Impact of Health Care Funding on overall Survival of Patients with Multiple Myeloma and Monoclonal Gammopathy of Uncertain Significance.

Phase 1/2 Clinical Trial of HQK-1001, An Oral Fetal Hemoglobin Stimulant, In Sickle Cell Anemia

Therapeutic Response to Granulocyte Colony-Stimulating Factor in a Case of Selective IgA Deficiency (SIgAD) with Chronic Neutropenia.

Novel Three– and Four–Drug Combinations of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Newly Diagnosed Multiple Myeloma: Encouraging Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study.

High through-Put Screening of Chemicals That Stimulate Iron Uptake: A Novel Approach to Discovery of Anti-Cancer Drugs

Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study

DMT1 Expression Is Regulated by DMT1 Associated Protein (DAP) in K562 Cells.

Inpatient Pharmaceutical Cost of Hematological Agents: A Single Center Report.

Therapeutic Dilemma of Chemotherapy Dosing in Morbidly Obese Patient with AML: A Case Report and a Review of the Literature.

Protoporphyrin IX Down-Regulates DMT1 Associated Protein (DAP) in K562 Cells.

The Interaction of MOZ-TIF2 with Histone Chaperon Proteins CAF-1A and Asf1b Alters MOZ Regulated Gene Expression.

Iron Transport in Intestinal Epithelial Cells Occurs by Transcytosis. A Fluorescent Metal-Sensor Study.

The DMT1 Associated Protein (DAP) Regulates Iron Uptake by Erythroid Cells.

Troglitazone Exerts a Cell-Dependent Effect on the Extracellular Secretion of VEGF 165 Independently from the Rapamycin Sensitivity or the Level of eIF4E Expression in AML-Derived Cells.

Altered Expression Profile of Global Genes in U937 Cells Stably Transfected with a Leukemia Fusion Gene: MOZ-TIF2.

Apo-transferrin is internalized and routed differently from Fe-transferrin by Caco-2 cells: a confocal microscopy study of vesicular transport in intestinal cells

The Effect of Apotransferrin on Iron Release From Caco-2 Cells, an Intestinal Epithelial Cell Line

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only